{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "459",
                "469"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Propafenon"
        },
        {
            "identifier": "T2",
            "position": [
                "470",
                "488"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "150mg 3 x dziennie"
        },
        {
            "identifier": "T3",
            "position": [
                "538",
                "597"
            ],
            "subtype": "Behaviour",
            "type": "T",
            "value": "Udzielono instrukta\u017c post\u0119powania pacjentowi w razie napadu"
        },
        {
            "identifier": "T4",
            "position": [
                "624",
                "636"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "cz\u0119stoskurcz"
        },
        {
            "identifier": "T5",
            "position": [
                "668",
                "693"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "wykonanie pr\u00f3by Valsalvy,"
        },
        {
            "identifier": "T6",
            "position": [
                "694",
                "714"
            ],
            "subtype": "Behaviour",
            "type": "T",
            "value": "prowokacja wymiot\u00f3w,"
        },
        {
            "identifier": "T7",
            "position": [
                "715",
                "733"
            ],
            "subtype": "Behaviour",
            "type": "T",
            "value": "och\u0142odzenie twarzy"
        },
        {
            "identifier": "T8",
            "position": [
                "1030",
                "1063"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Napadowy cz\u0119stoskurcz nadkomorowy"
        },
        {
            "identifier": "T9",
            "position": [
                "1303",
                "1327"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "cz\u0119stoskurczu napadowego"
        },
        {
            "identifier": "T10",
            "position": [
                "1464",
                "1488"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zaburzeniami rytmu serca"
        },
        {
            "identifier": "T11",
            "position": [
                "1711",
                "1738"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "nadkomorowym cz\u0119stoskurczem"
        },
        {
            "identifier": "T12",
            "position": [
                "1760",
                "1768"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Metocard"
        },
        {
            "identifier": "T13",
            "position": [
                "1794",
                "1811"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergiczny"
        },
        {
            "identifier": "T14",
            "position": [
                "1812",
                "1818"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "ujemny"
        },
        {
            "identifier": "T15",
            "position": [
                "489",
                "523"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Kontrola w Poradni Kardiologicznej"
        },
        {
            "identifier": "T16",
            "position": [
                "524",
                "537"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za 6 miesi\u0119cy"
        },
        {
            "identifier": "T17",
            "position": [
                "340",
                "350"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Propafenon"
        },
        {
            "icd": "ICD10:I47.9",
            "identifier": "N1",
            "referenced": "T4",
            "subtype": "Reference",
            "type": "N",
            "value": "Cz\u00c4\u0099stoskurcz napadowy, nieokre\u00c5\u009blony"
        },
        {
            "icd": "ICD10:I47.1",
            "identifier": "N2",
            "referenced": "T8",
            "subtype": "Reference",
            "type": "N",
            "value": "Cz\u00c4\u0099stoskurcz nadkomorowy"
        },
        {
            "icd": "ICD10:I47.1",
            "identifier": "N3",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Cz\u00c4\u0099stoskurcz nadkomorowy"
        },
        {
            "icd": "ICD10:I49.9",
            "identifier": "N4",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Zaburzenia rytmu serca, nieokre\u00c5\u009blone"
        },
        {
            "icd": "ICD10:I47.1",
            "identifier": "N5",
            "referenced": "T11",
            "subtype": "Reference",
            "type": "N",
            "value": "Cz\u00c4\u0099stoskurcz nadkomorowy"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N6",
            "referenced": "T13",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "arg1": "T1",
            "arg2": "T2",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T16",
            "arg2": "T3",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T16",
            "arg2": "T15",
            "identifier": "R3",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T14",
            "arg2": "T13",
            "identifier": "R5",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 16 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nPropafenon\n------------------------------------------------\nZalecenia\n------------------------------------------------\nPropafenon 150mg 3 x dziennie\nKontrola w Poradni Kardiologicznej za 6 miesi\u0119cy\nUdzielono instrukta\u017c post\u0119powania pacjentowi w razie napadu. Prosz\u0119 pr\u00f3bowa\u0107 przerwa\u0107 cz\u0119stoskurcz metodami niefarmakologicznymi- wykonanie pr\u00f3by Valsalvy, prowokacja wymiot\u00f3w, och\u0142odzenie twarzy, nast\u0119pnie skontaktowa\u0107 si\u0119 z lekarzem lub zg\u0142osi\u0107 si\u0119 do szpitala.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:I47.1|Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Napadowy cz\u0119stoskurcz nadkomorowy\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Obserwacja w kierunku cz\u0119stoskurczu napadowego.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z zaburzeniami rytmu serca przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan dobry\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nch\u0142opiec z nadkomorowym cz\u0119stoskurczem , na sta\u0142e otrzymuje Metocard, skierowany na badania , wywiad alergiczny ujemny\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:4.80[mmol/L]\nS\u00f3d: Na:146.00[mmol/L]\nMorfologia\n    WBC:5.64[10\\\\^3/ul]\n    RBC:5.50[10\\\\^6/ul]\n    HGB:16.2[g/dl]\n    HCT:45.6[%]\n    MCV:82.9[fl]\n    MCH:29.5[pg]\n    MCHC:35.5[g/dl]\n    PLT:215.0[10\\\\^3/ul]\n    RDW-SD:36.0[fl]\n    RDW-CV:11.9[%]\n    PDW:14.0[fl]\n    MPV:11.1[fl]\n    P-LCR:34.1[%]\n    PCT:0.2[%]\n    NEUTR#:2.68[10\\\\^3/ul]\n    NEUTR%:47.5[%]\n    LYMPH#:2.29[10\\\\^3/ul]\n    LYMPH%:40.6[%]\n    MONO#:0.51[10\\\\^3/ul]\n    MONO%:9.00[%]\n    EO#:0.10[10\\\\^3/ul]\n    EO%:1.80[%]\n    BASO#:0.06[10\\\\^3/ul]\n    BASO%:1.10[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:6.47[10\\\\^3/ul]\n    RBC:5.25[10\\\\^6/ul]\n    HGB:15.7[g/dl]\n    HCT:44.1[%]\n    MCV:84.0[fl]\n    MCH:29.9[pg]\n    MCHC:35.6[g/dl]\n    PLT:199.0[10\\\\^3/ul]\n    RDW-SD:36.1[fl]\n    RDW-CV:12.0[%]\n    PDW:13.2[fl]\n    MPV:10.8[fl]\n    P-LCR:31.4[%]\n    PCT:0.2[%]\n    NEUTR#:4.36[10\\\\^3/ul]\n    NEUTR%:67.3[%]\n    LYMPH#:1.50[10\\\\^3/ul]\n    LYMPH%:23.2[%]\n    MONO#:0.40[10\\\\^3/ul]\n    MONO%:6.20[%]\n    EO#:0.16[10\\\\^3/ul]\n    EO%:2.50[%]\n    BASO#:0.05[10\\\\^3/ul]\n    BASO%:0.80[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Erym:4 /uL \u015bw.[ul]\n    Leum:3 /uL[ul]\n    Bakm:pojedyncze[wpw]\n    NabP\u0142m:pojedyncze[wpw]\n    Pas\u015al:nieliczny[wpw]\nBadanie og\u00f3lne moczu\n    Barwa:jasno\u017c\u00f3\u0142ta\n    Przej:zupe\u0142na\n    SG:1.014\n    pH:6.5\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecna[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:52.00[mg/dl]\nBadanie og\u00f3lne moczu\n    Barwa:\u017c\u00f3\u0142ta\n    Przej:zupe\u0142na\n    SG:1.015\n    pH:6.0\n    LEU:obecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cony\n    BIL:nieobecna\n    ERY:nieobecne[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:486.0[ng/ml]\nFibrynogen (F): FIB:2.28[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:30.0[s]\nINR: INR:1.3\nCzas protrombinowy (PT): PT:14.2[s]\nCzas trombinowy (TT): TT:15.2[s]\nChlorki: Cl:104.00[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.61[mmol/L]\nKwas mlekowy: LAC:14.20[mg/dl]\nKwas mlekowy: LAC:77.80[mg/dl]\nCK - kinaza kreatynowa: CK:94.00[IU/L]\nMagnez: Mg:0.83[mmol/L]\nLDH dehydrogenaza mleczanowa: LDH:510.00[IU/L]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:77[%]\nKreatynina: CREA:0.90[mg/dl]\nKreatynina: CREA:0.80[mg/dl]\nKreatynina: CREA:0.95[mg/dl]\nMocznik: UREA:25.00[mg/dl]\nMocznik: UREA:30.00[mg/dl]\nMocznik: UREA:24.00[mg/dl]\nASPAT: AST:20.00[IU/L]\nASPAT: AST:16.00[IU/L]\nALAT: ALT:30.00[IU/L]\nALAT: ALT:30.00[IU/L]\nNT- proBNP\n    NTpBNP:\n    20.00[pg/ml]\nNT- proBNP\n    NTpBNP:\n    20.00[pg/ml]\nTSH: TSH:1.02[uIU/ml]\nTSH: TSH:0.84[uIU/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:11.00[IU/L]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:82.6[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:93.4[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:78.7[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:180[cm]\nWzrost pacjenta: WzrostPac:181[cm]\nWzrost pacjenta: WzrostPac:181[cm]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:140.0[ml/min/1,73m2]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:158.4[ml/min/1,73m2]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:133.4[ml/min/1,73m2]\nFT3 III: FT3 III:3.21[pg/ml]\nFT3 III: FT3 III:3.55[pg/ml]\nFT4II: FT4II:1.24[ng/dl]\nFT4II: FT4II:1.20[ng/dl]\nBadanie osadu z moczu odwirowanego\n    werytrocyt:3/ul \u015bw. i cz. wy\u0142[ul]\n    wkrwbia\u0142e:11/ul[ul]\n    wnab\u0142onekp:nieliczne w pw\n    w\u015bluz:nieliczne pasma\n------------------------------------------------\nICD10\n------------------------------------------------\nI47.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\nO69\nG21\nG25\n87.699\n89.541\nL69\n------------------------------------------------"
}